Today's journal articles

Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials.

Lack of an Effect of Ceftriaxone, a GLT - 1 Transporter Activator, on Spatial Memory in Mice.

Do you need further information on any of the agents being evaluated in the trial(s) below?  Let us know...

New Clinical Trials

No clinical trials today

Previous Journal Entries

Adherence to depot versus oral antipsychotic medication in schizophrenic patients during the long-term therapy.

Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test Performance.

Stimulation of Metabotropic Glutamate (mGlu) 2 Receptor and Blockade of mGlu1 Receptor Improve Social Memory Impairment Elicited by MK-801 in Rats.

Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.

Altered Cytokine and BDNF Levels in Autism Spectrum Disorder.

Exogenous Interleukin-6 Facilitated the Contraction of the Colon in a Depression Rat Model.

A 10-month, open-label evaluation of desvenlafaxine in Japanese outpatients with major depressive disorder.

Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors.

A Randomized Trial on the Acute and Steady-State Effects of a New Antidepressant, Vortioxetine (Lu AA21004), on Actual Driving and Cognition.

Trends in the prescribing of psychotropic medications for inpatient children and adolescents, 2000-2010: a study from China.

Reduced Binding Potential of GABA-A/Benzodiazepine Receptors in Individuals at Ultra-high Risk for Psychosis: An [18F]-Fluoroflumazenil Positron Emission Tomography Study.

A randomised, controlled trial of a dietary intervention for adults with major depression (the "SMILES" trial): study protocol.

Effect of tipepidine with novel antidepressant-like action on c-fos-like protein expression in rat brain.

DISC1-ATF4 transcriptional repression complex: dual regulation of the cAMP-PDE4 cascade by DISC1.

Prophylactic Effects of Duloxetine on Post-Stroke Depression Symptoms: An Open Single-Blind Trial.

The Role of Depression in Medication Adherence Among Heart Failure Patients.

Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder.

The Pharmacoepidemiology of Selective Serotonin Reuptake Inhibitors for Children and Adolescents in Canada from 2005 to 2009: A Database Analysis.

Activation of PPARγ by Pioglitazone Potentiates the Effects of Naltrexone on Alcohol Drinking and Relapse in msP Rats.

αCaMKII Autophosphorylation Controls the Establishment of Alcohol Drinking Behavior.

Today's News Items

No news items selected today

Training Courses & Meetings

No events listed

Previous News Items

New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome

Takeda and Lundbeck Present Results from Pivotal Phase 3 Clinical Trials with Vortioxetine, an Investigational Compound for Major Depressive Disorder

Merck Statement on FDA Advisory Committee Meeting for Suvorexant

Takeda and Lundbeck Present Results from Pivotal Phase 3 Clinical Trials with Vortioxetine, an Investigational Compound for Major Depressive Disorder

---

For faster discovery, automatically organize PubMed results into categories